Anti-IgE (omalizumab) inhibits late-phase reactions and inflammatory cells after repeat skin allergen challenge
- 30 September 2005
- journal article
- clinical trial
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 116 (3), 558-564
- https://doi.org/10.1016/j.jaci.2005.05.035